Medinice hopes to sell its first medtech project next year

Medinice is hoping to sell its first medtech project next year, president Sanjeev Choudhary told ISBtech.

“Medinice is currently focusing on 5 priority projects, although the pipeline has over 12 and 60 patents and applications. We hope that the commercialization of our projects will have a positive impact on the company's future financial results. Our goal is to sell the first project next year, ”Choudhary told ISBtech.

The key projects that the company is currently working on include: the MiniMax project, a 2-in-1 electrode used to perform current ablation procedures; CoolCryo - a cryopalicator for minimally invasive cardiac cryoablation; PacePress - a compression dressing designed to reduce the risk of a hematoma. He is also working on the EP Bioptom solution, i.e. an electrophysiological diagnostic electrode for endomyocardial biopsy, and on AtriClamp - an innovative technology for closing the appendix of the left atrium of the heart (LAAO).

Medinice is a Polish company with a global reach, being a platform for solutions used in cardiology. The company develops its own projects and projects obtained from scientists from Poland and abroad. The team consists of professionals in the field of medicine, clinical trials, law (in particular intellectual property) and finance. The company made its debut on the WSE main market in December 2020.

Our privacy policy